-
Chang‐Deng
Hu,
Y.
Chinenov,
T.
Kerppola
(2002)
Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation.
Molecular cell, 9 4
-
Connor CE
(2001)
2917
Cancer Res., 61
-
E.
Alarid
(2006)
Lives and times of nuclear receptors.
Molecular endocrinology, 20 9
-
C.
Eakin,
M.
MacCoss,
Greg
Finney,
R.
Klevit
(2007)
Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.
Proceedings of the National Academy of Sciences of the United States of America, 104 14
-
Shen
(2001)
Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294
Mol. Cell. Biol., 21
-
D.
Lonard,
Z.
Nawaz,
C.
Smith,
B.
O’Malley
(2000)
The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation.
Molecular cell, 5 6
-
T.
Shen,
K.
Horwitz,
Carol
Lange
(2001)
Kinase-dependent Phosphorylation of Mitogen-activated Protein Ligand-dependent Down-regulation by Their Progesterone Receptors Is Coupled to Transcriptional Hyperactivity of Human
-
Zeynep
Madak-Erdogan,
M.
Lupien,
F.
Stossi,
Myles
Brown,
B.
Katzenellenbogen
(2010)
Genomic Collaboration of Estrogen Receptor α and Extracellular Signal-Regulated Kinase 2 in Regulating Gene and Proliferation Programs
Molecular and Cellular Biology, 31
-
D.
Hershko
(2008)
Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer
Cancer, 112
-
K.
Nakayama,
K.
Nakayama
(2006)
Ubiquitin ligases: cell-cycle control and cancer
Nature Reviews Cancer, 6
-
Carol
Lange,
T.
Shen,
K.
Horwitz
(2000)
Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome.
Proceedings of the National Academy of Sciences of the United States of America, 97 3
-
Yeliz
Utku,
E.
Dehan,
O.
Ouerfelli,
F.
Piano,
R.
Zuckermann,
M.
Pagano,
K.
Kirshenbaum
(2006)
A peptidomimetic siRNA transfection reagent for highly effective gene silencing.
Molecular bioSystems, 2 6-7
-
M.
Fan,
Annie
Park,
K.
Nephew
(2005)
CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha.
Molecular endocrinology, 19 12
-
B.
Katzenellenbogen,
J.
Frasor
(2004)
Therapeutic targeting in the estrogen receptor hormonal pathway.
Seminars in oncology, 31 1 Suppl 3
-
Peng
Ji,
Luba
Goldin,
Hao
Ren,
Daqian
Sun,
D.
Guardavaccaro,
M.
Pagano,
Liang
Zhu
(2006)
Skp2 Contains a Novel Cyclin A Binding Domain That Directly Protects Cyclin A from Inhibition by p27Kip1*
Journal of Biological Chemistry, 281
-
S.
Radke,
Andreja
Pirkmaier,
D.
Germain
(2005)
Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer
Oncogene, 24
-
Byun B
(2008)
289
Mol. Cells, 25
-
A.
Bergamaschi,
B.
Christensen,
B.
Katzenellenbogen
(2011)
Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis
Breast Cancer Research : BCR, 13
-
A.
Brodie
(1994)
Aromatase inhibitors in the treatment of breast cancer
The Journal of Steroid Biochemistry and Molecular Biology, 49
-
S.
Johnston,
L.
Martin,
A.
Leary,
J.
Head,
M.
Dowsett
(2007)
Clinical strategies for rationale combinations of aromatase inhibitors with novel therapies for breast cancer
The Journal of Steroid Biochemistry and Molecular Biology, 106
-
T.
Bashir,
N.
Dorrello,
V.
Amador,
D.
Guardavaccaro,
M.
Pagano
(2004)
Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
Nature, 428 6979
-
Karen
Kieser,
D.
Kim,
K.
Carlson,
B.
Katzenellenbogen,
J.
Katzenellenbogen
(2010)
Characterization of the pharmacophore properties of novel selective estrogen receptor downregulators (SERDs).
Journal of medicinal chemistry, 53 8
-
S.
Signoretti,
L.
Marcotullio,
A.
Richardson,
Sridhar
Ramaswamy,
Beth
Isaac,
M.
Rue,
F.
Monti,
M.
Loda,
M.
Pagano
(2002)
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.
The Journal of clinical investigation, 110 5
-
F.
Stossi,
Zeynep
Madak-Erdogan,
B.
Katzenellenbogen
(2009)
Estrogen Receptor Alpha Represses Transcription of Early Target Genes via p300 and CtBP1
Molecular and Cellular Biology, 29
-
C.
Huang,
T.
Uno,
J.
Murphy,
S.
Lee,
J.
Hamer,
J.
Escobedo,
F.
Cohen,
R.
Radhakrishnan,
V.
Dwarki,
R.
Zuckermann
(1998)
Lipitoids--novel cationic lipids for cellular delivery of plasmid DNA in vitro.
Chemistry & biology, 5 6
-
C.
Atsriku,
D.
Britton,
Jason
Held,
B.
Schilling,
G.
Scott,
B.
Gibson,
C.
Benz,
M.
Baldwin
(2008)
receptor alpha, with emphasis on novel phosphorylation sites
-
Reidun
Aesoy,
B.
Sanchez,
J.
Norum,
R.
Lewensohn,
K.
Viktorsson,
B.
Linderholm
(2008)
An Autocrine VEGF/VEGFR2 and p38 Signaling Loop Confers Resistance to 4-Hydroxytamoxifen in MCF-7 Breast Cancer Cells
Molecular Cancer Research, 6
-
Vladimir
Stanišić,
A.
Malovannaya,
J.
Qin,
D.
Lonard,
B.
O’Malley
(2009)
OTU Domain-containing Ubiquitin Aldehyde-binding Protein 1 (OTUB1) Deubiquitinates Estrogen Receptor (ER) α and Affects ERα Transcriptional Activity*
The Journal of Biological Chemistry, 284
-
Hui-Kuan
Lin,
Guocan
Wang,
Zhenbang
Chen,
J.
Teruya-Feldstein,
Yan
Liu,
Chia-Hsin
Chan,
Wei-Lei
Yang,
H.
Erdjument-Bromage,
K.
Nakayama,
S.
Nimer,
P.
Tempst,
P.
Pandolfi
(2009)
Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB
Nature Cell Biology, 11
-
Boo-hyeong
Byun,
Yunhwa
Jung
(2008)
Repression of transcriptional activity of estrogen receptor alpha by a Cullin3/SPOP ubiquitin E3 ligase complex.
Molecules and cells, 25 2
-
A.
Ravaioli,
F.
Monti,
M.
Regan,
F.
Maffini,
M.
Mastropasqua,
V.
Spataro,
M.
Castiglione‐Gertsch,
I.
Panzini,
L.
Gianni,
A.
Goldhirsch,
A.
Coates,
K.
Price,
B.
Gusterson,
G.
Viale
(2007)
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology, 19 4
-
T.
Cardozo,
M.
Pagano
(2004)
The SCF ubiquitin ligase: insights into a molecular machine
Nature Reviews Molecular Cell Biology, 5
-
A.
Willems,
T.
Goh,
L.
Taylor,
I.
Chernushevich,
A.
Shevchenko,
M.
Tyers
(1999)
SCF ubiquitin protein ligases and phosphorylation-dependent proteolysis.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 354 1389
-
Richard
Eckert,
Alaka
Mullick,
E.
Rorke,
B.
Katzenellenbogen
(1984)
Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique.
Endocrinology, 114 2
-
F.
Montemurro,
M.
Aglietta,
L.
Mastro
(2009)
Aromatase inhibitors as adjuvant therapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 15
-
G.
Nalepa,
M.
Rolfe,
J.
Harper
(2006)
Drug discovery in the ubiquitin–proteasome system
Nature Reviews Drug Discovery, 5
-
Brueggemeier
(2005)
Aromatase inhibitors in the treatment of breast cancer
Endocr. Rev., 26
-
Nicholas
Berry,
M.
Fan,
K.
Nephew
(2008)
Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome.
Molecular endocrinology, 22 7
-
A.
Willems,
M.
Schwab,
M.
Tyers
(2004)
A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin.
Biochimica et biophysica acta, 1695 1-3
-
Yongxian
Ma,
S.
Fan,
Changyan
Hu,
Q.
Meng,
S.
Fuqua,
R.
Pestell,
Y.
Tomita,
E.
Rosen
(2010)
BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.
Molecular endocrinology, 24 1
-
F.
Gonzalez,
A.
Delahodde,
T.
Kodadek,
S.
Johnston
(2002)
Recruitment of a 19S Proteasome Subcomplex to an Activated Promoter
Science, 296
-
E.
Mcinerney,
Karen
Weis,
Jun
Sun,
S.
Mosselman,
B.
Katzenellenbogen
(1998)
Transcription Activation by the Human Estrogen Receptor Subtypeβ (ERβ) Studied with ERβ and ERα Receptor Chimeras* *This work was supported by NIH Grants CA-18119 and CA-60514 (to B.S.K.).
Endocrinology, 139 11
-
C.
Eakin,
M.
MacCoss,
Greg
Finney,
R.
Klevit
(2007)
Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase
Proceedings of the National Academy of Sciences, 104
-
R.
Riggins,
Randy
Schrecengost,
Michael
Guerrero,
A.
Bouton
(2007)
Pathways to tamoxifen resistance.
Cancer letters, 256 1
-
Isabel
Chu,
A.
Arnaout,
S.
Loiseau,
Jun
Sun,
A.
Seth,
C.
Mcmahon,
Kathy
Chun,
B.
Hennessy,
G.
Mills,
Z.
Nawaz,
J.
Slingerland
(2007)
Src promotes estrogen-dependent estrogen receptor α proteolysis in human breast cancer
Journal of Clinical Investigation, 117
-
D.
Guardavaccaro,
M.
Pagano
(2006)
Stabilizers and destabilizers controlling cell cycle oscillators.
Molecular cell, 22 1
-
Yixin
Wang,
J.
Klijn,
Yi
Zhang,
A.
Sieuwerts,
M.
Look,
Fei
Yang,
D.
Talantov,
M.
Timmermans,
M.
Gelder,
Jack
Yu,
T.
Jatkoe,
E.
Berns,
D.
Atkins,
J.
Foekens
(2005)
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
The Lancet, 365
-
Caroline
Connor,
J.
Norris,
G.
Broadwater,
T.
Willson,
M.
Gottardis,
M.
Dewhirst,
D.
McDonnell
(2001)
Circumventing tamoxifen resistance in breast cancers using antiestrogens that induce unique conformational changes in the estrogen receptor.
Cancer research, 61 7
-
S.
Dauvois,
P.
Danielian,
Roger
White,
Malcolm
Parker
(1992)
Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover.
Proceedings of the National Academy of Sciences of the United States of America, 89
-
Edmund
Chang,
T.
Charn,
Sung-Hee
Park,
W.
Helferich,
Barry
Komm,
J.
Katzenellenbogen,
B.
Katzenellenbogen
(2008)
Estrogen Receptors (cid:1) and (cid:2) as Determinants of Gene Expression: Influence of Ligand, Dose, and Chromatin Binding
-
M.
Gstaiger,
R.
Jordan,
Megan
Lim,
C.
Catzavelos,
J.
Mestan,
J.
Slingerland,
W.
Krek
(2001)
Skp2 is oncogenic and overexpressed in human cancers
Proceedings of the National Academy of Sciences of the United States of America, 98
-
R.
Métivier,
G.
Penot,
Michaela
Hübner,
G.
Reid,
H.
Brand,
M.
Koš,
F.
Gannon
(2003)
Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target Promoter
Cell, 115
-
D.
Lonard,
Z.
Nawaz,
Carolyn
Smith,
B.
O’Malley
(2000)
The 26S Proteasome Is Required for Estrogen Receptor-α and Coactivator Turnover and for Efficient Estrogen Receptor-α Transactivation
Molecular Cell, 5
-
E.
Musgrove,
R.
Sutherland
(2009)
Biological determinants of endocrine resistance in breast cancer
Nature Reviews Cancer, 9
-
V.
Jordan,
Bert
O’Malley
(2007)
Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 36
-
G.
Reid,
Michaela
Hübner,
R.
Métivier,
H.
Brand,
S.
Denger,
Dominique
Manu,
J.
Beaudouin,
J.
Ellenberg,
F.
Gannon
(2003)
Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling.
Molecular cell, 11 3
-
S.
Reed
(2008)
Deathproof: new insights on the role of skp2 in tumorigenesis.
Cancer cell, 13 2
-
J.
Frasor,
Jeanne
Danes,
B.
Komm,
Ken
Chang,
C.
Lyttle,
B.
Katzenellenbogen
(2003)
Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.
Endocrinology, 144 10
-
Daming
Gao,
H.
Inuzuka,
A.
Tseng,
R.
Chin,
A.
Toker,
Wenyi
Wei
(2009)
Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction
Nature Cell Biology, 11
-
C.
Atsriku,
D.
Britton,
Jason
Held,
B.
Schilling,
G.
Scott,
B.
Gibson,
C.
Benz,
M.
Baldwin
(2009)
Systematic Mapping of Posttranslational Modifications in Human Estrogen Receptor-α with Emphasis on Novel Phosphorylation Sites*S
Molecular & Cellular Proteomics, 8
-
Y.
Shang,
Xiao
Hu,
J.
Direnzo,
M.
Lazar,
Myles
Brown
(2000)
Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription
Cell, 103
-
Isabel
Chu,
A.
Arnaout,
S.
Loiseau,
Jun
Sun,
A.
Seth,
C.
Mcmahon,
Kathy
Chun,
B.
Hennessy,
G.
Mills,
Z.
Nawaz,
J.
Slingerland
(2007)
Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.
The Journal of clinical investigation, 117 8
-
I.
Laı̈os,
F.
Journé,
D.
Nonclercq,
D.
Vidal,
R.
Toillon,
G.
Laurent,
G.
Leclercq
(2005)
Role of the proteasome in the regulation of estrogen receptor α turnover and function in MCF-7 breast carcinoma cells
The Journal of Steroid Biochemistry and Molecular Biology, 94
-
Jian-Jun
Zhao,
Jianhong
Lin,
Huan
Yang,
W.
Kong,
Lili
He,
Xu
Ma,
D.
Coppola,
J.
Cheng
(2008)
MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer*
Journal of Biological Chemistry, 283
-
F.
Monsma,
B.
Katzenellenbogen,
M.
Miller,
Y.
Ziegler,
J.
Katzenellenbogen
(1984)
Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.
Endocrinology, 115 1
-
Signoretti
(2002)
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer
J. Clin. Invest., 110
-
D.
Calvisi,
S.
Ladu,
F.
Pinna,
M.
Frau,
M.
Tomasi,
M.
Sini,
M.
Simile,
P.
Bonelli,
M.
Muroni,
M.
Seddaiu,
D.
Lim,
F.
Feo,
R.
Pascale
(2009)
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Gastroenterology, 137 5
-
S.
Ramamoorthy,
Zafar
Nawaz
(2008)
E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors
Nuclear Receptor Signaling, 6